FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:730-732 February 12, 2004 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group PubMed Citation

To the Editor: The use of protease-inhibitor drugs is associated with increased levels of triglycerides, total cholesterol, and low-density lipoprotein cholesterol and with diabetic diathesis in patients infected with the human immunodeficiency virus (HIV).¹ Because these metabolic problems can lead to cardiovascular disease, we examined data from the HIV Outpatient Study (HOPS), which involved a large cohort of HIV-infected outpatients followed at nine HIV clinics in seven U.S. cities: 3247 patients who had taken protease inhibitors for more than six months, and 2425 patients who had not taken protease inhibitors. These patients were followed for a total of 17,712 person-years . . . [Full Text of this Article]

This article has been cited by other articles:

• Vellozzi, C., Brooks, J. T., Bush, T. J., Conley, L. J., Henry, K., Carpenter, C. C. J., Overton, E. T., Hammer, J., Wood, K., Holmberg, S. D., the SUN Study Investigators, (2009). The Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study). Am J Epidemiol 169: 642-652 [Abstract] [Full Text]  
• Currier, J. S., Lundgren, J. D., Carr, A., Klein, D., Sabin, C. A., Sax, P. E., Schouten, J. T., Smieja, M., for Working Group 2, (2008). Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients and Relationship to Highly Active Antiretroviral Therapy. Circulation 118: e29-e35 [Full Text]  
• Versari, D., Herrmann, J., Gossl, M., Mannheim, D., Sattler, K., Meyer, F. B., Lerman, L. O., Lerman, A. (2006). Dysregulation of the Ubiquitin-Proteasome System in Human Carotid Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 26: 2132-2139 [Abstract] [Full Text]  
• Zhou, H., Pandak, W. M. Jr., Lyall, V., Natarajan, R., Hylemon, P. B. (2005). HIV Protease Inhibitors Activate the Unfolded Protein Response in Macrophages: Implication for Atherosclerosis and Cardiovascular Disease. Mol. Pharmacol. 68: 690-700 [Abstract] [Full Text]  
• Chou, R., Huffman, L. H., Fu, R., Smits, A. K., Korthuis, P. T. (2005). Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 143: 55-73 [Abstract] [Full Text]